WHO ICTRP trial
A clinical study to determine the safety and a combined effect of the Test…
CTRI/2022/02/040184 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/02/040184 |
|---|---|
| Public title | A clinical study to determine the safety and a combined effect of the Test products Skidel Bar with TEP-AD Lotion (with/without parabiotics) and Skidel Foam with TEP-AD Lotion (with/without parabiotics) in Healthy Human Subjects with light to medium red and itchy skin (8-Weeks Home Use Test) |
| Scientific title | A Synergy, Safety, Efficacy, Skin Compatibility Study of Skidel Bar, Skidel Foam and TEP-AD Daily Lotion in Healthy Human Subjects with Mild to Moderate Atopic Dermatitis in 8-Weeks Home Use Test. - NB220002 |
| Primary sponsor | Inzpera Healthsciences Limited |
| Secondary sponsors | Not Applicable |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Interventions | Intervention1: Treatment A) Combination of Skidel Bar and Tep-AD Daily Lotion (with parabiotics): Skidel Bar: Sulfate-free parabiotic cleanser, the unique blend of ingredients like Avocado Oil and Shea butter Tep-AD Daily Lotion is the… |
| Registration date | Oct 2, 2022 |
| Target size | 64 |
| Secondary IDs | NB220002-IH, Version No. 01 (Final), 02 Feb 2022 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: